相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a Clinical Chemiluminescent Immunoassay for Serum GPC3 and Simultaneous Measurements Alone With AFP and CK19 in Diagnosis of Hepatocellular Carcinoma
Juan-Ping Yu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2015)
Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysis
Xiao-Fei Liu et al.
CLINICAL BIOCHEMISTRY (2014)
Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
Hyun Jung Lee et al.
GUT AND LIVER (2014)
Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis
Yichen Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis-C virus cirrhosis
Eman A. E. Badr et al.
ALEXANDRIA JOURNAL OF MEDICINE (2014)
Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients
B. Li et al.
AFRICAN HEALTH SCIENCES (2013)
Can Glypican3 be Diagnostic for Early Hepatocellular Carcinoma among Egyptian Patients?
Iman Attia Abdelgawad et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
Jean-Charles Nault et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
Min Chen et al.
CLINICA CHIMICA ACTA (2013)
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
Cheng Xu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol
Ting-Shuo Huang et al.
SYSTEMATIC REVIEWS (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC
Wen Wang et al.
CANCER BIOMARKERS (2012)
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
Sean F. Altekruse et al.
HEPATOLOGY (2012)
New Serum Markers of Hepatocellular Carcinoma
Ryota Masuzaki et al.
SEMINARS IN ONCOLOGY (2012)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
Diagnostic and Prognostic Role of Serum Glypican 3 in Patients With Hepatocellular Carcinoma
Hasan Ozkan et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2011)
Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
Masahiro Tanaka et al.
JOURNAL OF EPIDEMIOLOGY (2011)
Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma
Qianyun Zhang et al.
CLINICAL BIOCHEMISTRY (2010)
Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
Eisuke Yasuda et al.
HEPATOLOGY RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers
Pisit Tangkijvanich et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma
Hui Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
Gary Beale et al.
BMC CANCER (2008)
Glypican-3 immunocytochemistry in liver fine-needle aspirates - A novel stain to assist in the differentiation of benign and malignant liver lesions
Dina Kandil et al.
CANCER CYTOPATHOLOGY (2007)
Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma
Hu-Liang Jia et al.
CLINICAL CANCER RESEARCH (2007)
The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells
Petar N. Grozdanov et al.
LABORATORY INVESTIGATION (2006)
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
JJ Deeks et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma
Y Hippo et al.
CANCER RESEARCH (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
T Nakatsura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
分享论文
